AHRQ: More evidence needed on DMARD use in juvenile arthritis

09/28/2011 | HealthDay News

Although disease-modifying anti-rheumatic drugs appear to be more effective for treating juvenile idiopathic arthritis than ibuprofen or steroids, not much evidence concerning long-term use exists, according to the Agency for Healthcare Research and Quality. Data indicated better health outcomes in children who received DMARDs, but the researchers noted that there was insufficient data to compare different classes of DMARDs.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC